Gastrointestinal Langerhans cell histiocytosis responding to cladribine and imatinib mesylate

Agreda Vásquez, Gladys Patricia y Popoca Barriga, Ulises y Oviedo, Edgar y Lome Maldonado, Carmen y Sánchez Guerrero, Sergio Arturo (2010) Gastrointestinal Langerhans cell histiocytosis responding to cladribine and imatinib mesylate. Medicina universitaria, 12 (47). pp. 131-134. ISSN 1665-5796

[img]
Vista previa
Texto
Gastrointestinal Langerhans.pdf - Versión Publicada
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (424kB) | Vista previa

Resumen

Gastrointestinal involvement in Langerhans cells histiocytosis (LCH) is extremely rare. An optimal treatment regimen is not defined yet and its prognosis is relatively poor. Cladribine, and more recently, Imatinib mesylate (IM) have been recommended as treatment options in refractory LCH. Here we present a case of gastrointestinal involvement in an adult patient with LCH refractory to several treatment regimens who responded nicely to cladribine and currently treated with IM 300 mg/day, as maintenance, for the last 24 months.

Tipo de elemento: Article
Palabras claves no controlados: Langerhans cells, Histiocytosis, Cladribine, Imatinib, 2CDA, Mexico
Divisiones: Medicina
Usuario depositante: Lic. Josimar Pulido
Creadores:
CreadorEmailORCID
Agreda Vásquez, Gladys Patriciapatyr2mi@hotmail.comNO ESPECIFICADO
Popoca Barriga, UlisesNO ESPECIFICADONO ESPECIFICADO
Oviedo, EdgarNO ESPECIFICADONO ESPECIFICADO
Lome Maldonado, CarmenNO ESPECIFICADONO ESPECIFICADO
Sánchez Guerrero, Sergio Arturosasanche@prodigy.net.mxNO ESPECIFICADO
Fecha del depósito: 20 Ene 2016 03:55
Última modificación: 20 Ene 2016 03:55
URI: http://eprints.uanl.mx/id/eprint/8449

Actions (login required)

Ver elemento Ver elemento

Downloads

Downloads per month over past year